CLOV vs HTFL
CLOV: Clover Health combines Medicare Advantage insurance with a proprietary, AI-driven clinical decision-support platform designed to improve health outcomes and manage costs for Medicare beneficiaries. HTFL: HeartFlow uses AI-powered software to transform standard cardiac scans into actionable 3D insights for non-invasive coronary artery disease diagnosis and treatment planning.
Side-by-side fundamentals
| Metric | CLOV | HTFL | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $4.14 | $27.17 | |
| Market cap as of 2026-08-06 | $2.2B | $2.3B | |
| PEG as of 2026-08-06 | -0.32 | n/a | |
| Net margin as of 2026-08-06 | -2.6% | -58.4% | CLOV higher |
| Gross margin as of 2026-08-06 | n/a | +78.1% | |
| Operating margin as of 2026-08-06 | -2.6% | -43.1% | CLOV higher |
| ROE as of 2026-08-06 | -17.1% | -38.9% | CLOV higher |
| ROA as of 2026-08-06 | -9.6% | -36.4% | CLOV higher |
| Debt / equity as of 2026-08-06 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-08-06 | +48.8% | +41.3% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +20.6% | +42.1% | HTFL higher |
| Beta as of 2026-08-06 | 2.51 | 2.01 | |
| 1-year return as of 2026-08-05 close | +45.3% | n/a |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.